INTANGIBLE ASSETS (Tables)

12 Months Ended

Dec. 31, 2015

Intangible assets, net consisted of the following at December 31:

Intangible assets	2015			2014
Patent - Amlexanox (Aphthasol®)	$	2,090,000		$	2,090,000
Patent - Amlexanox (OraDisc™ A)		6,873,080			6,873,080
Patent - OraDisc™		73,000			73,000
Patent - Hydrogel nanoparticle aggregate		589,858			589,858
		9,625,938			9,625,938
Less: accumulated amortization		(6,905,397	)		(6,430,249	)
Intangible assets, net	$	2,720,541		$	3,195,689

The future aggregate amortization expense for intangible assets, remaining as of December 31, 2015, is as follows:

Calendar Years	Future Amortization Expense
2016	$	476,450
2017		475,148
2018		475,148
2019		475,148
2020		476,450
2021 & Beyond		342,197
Total	$	2,720,541